In addition to artesunate, other pharmacological GDF15 inducers, including camptothecin and metformin, have been shown to confer anti-obesity effects with comparable efficacies41–43. The gene discussed is GDF15; the disease is obesity due to melanocortin 4 receptor deficiency.